Alimera Sciences Announces Positive Outcome to the European Decentralized Procedure for Approval of ILUVIEN(R) for the Treatment of Chronic Diabetic Macular Edema

Alimera Sciences has received a positive outcome tot he European Decentralized Procedure for approval of Iluvien, its drug to treat diabetic macular edema. It is expected to be the first sustained release pharmaceutical in the EU to treat DME.... [more]

View complete Press Release article